Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Multimodal molecular imaging of integrin αvβ3 for in vivo detection of pancreatic cancer.

Trajkovic-Arsic M, Mohajerani P, Sarantopoulos A, Kalideris E, Steiger K, Esposito I, Ma X, Themelis G, Burton N, Michalski CW, Kleeff J, Stangl S, Beer AJ, Pohle K, Wester HJ, Schmid RM, Braren R, Ntziachristos V, Siveke JT.

J Nucl Med. 2014 Mar;55(3):446-51. doi: 10.2967/jnumed.113.129619. Epub 2014 Feb 18.

2.

Does imaging αvβ3 integrin expression with PET detect changes in angiogenesis during bevacizumab therapy?

Rylova SN, Barnucz E, Fani M, Braun F, Werner M, Lassmann S, Maecke HR, Weber WA.

J Nucl Med. 2014 Nov;55(11):1878-84. doi: 10.2967/jnumed.114.137570. Epub 2014 Oct 2.

3.

Molecular Imaging of Breast Cancer: Role of RGD Peptides.

Chakravarty R, Chakraborty S, Dash A.

Mini Rev Med Chem. 2015;15(13):1073-94. Review.

PMID:
26349490
4.

[68Ga]NODAGA-RGD for imaging αvβ3 integrin expression.

Knetsch PA, Petrik M, Griessinger CM, Rangger C, Fani M, Kesenheimer C, von Guggenberg E, Pichler BJ, Virgolini I, Decristoforo C, Haubner R.

Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1303-12. doi: 10.1007/s00259-011-1778-0. Epub 2011 Apr 13.

PMID:
21487838
5.

MicroPET/CT imaging of αvβ₃ integrin via a novel ⁶⁸Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction.

Menichetti L, Kusmic C, Panetta D, Arosio D, Petroni D, Matteucci M, Salvadori PA, Casagrande C, L'Abbate A, Manzoni L.

Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1265-74. doi: 10.1007/s00259-013-2432-9. Epub 2013 May 15.

PMID:
23674206
6.

Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis.

Dumont RA, Deininger F, Haubner R, Maecke HR, Weber WA, Fani M.

J Nucl Med. 2011 Aug;52(8):1276-84. doi: 10.2967/jnumed.111.087700. Epub 2011 Jul 15. Erratum in: J Nucl Med. 2011 Sep;52(9):1498.

7.
8.

Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄.

Aung W, Jin ZH, Furukawa T, Claron M, Boturyn D, Sogawa C, Tsuji AB, Wakizaka H, Fukumura T, Fujibayashi Y, Dumy P, Saga T.

Mol Imaging. 2013 Sep;12(6):376-87.

PMID:
23981783
9.

Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin.

Bunschoten A, Buckle T, Visser NL, Kuil J, Yuan H, Josephson L, Vahrmeijer AL, van Leeuwen FW.

Chembiochem. 2012 May 7;13(7):1039-45. doi: 10.1002/cbic.201200034. Epub 2012 Apr 13.

10.

(68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.

Liu Z, Niu G, Shi J, Liu S, Wang F, Liu S, Chen X.

Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):947-57. doi: 10.1007/s00259-008-1045-1. Epub 2009 Jan 22.

PMID:
19159928
11.

Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.

J Nucl Med. 2004 Oct;45(10):1776-83.

12.

Ligands for mapping alphavbeta3-integrin expression in vivo.

Schottelius M, Laufer B, Kessler H, Wester HJ.

Acc Chem Res. 2009 Jul 21;42(7):969-80. doi: 10.1021/ar800243b.

PMID:
19489579
13.

Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma.

Ueda M, Fukushima T, Ogawa K, Kimura H, Ono M, Yamaguchi T, Ikehara Y, Saji H.

Biochem Biophys Res Commun. 2014 Mar 14;445(3):661-6. doi: 10.1016/j.bbrc.2014.02.086. Epub 2014 Feb 26.

PMID:
24583127
14.

PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.

Beer AJ, Pelisek J, Heider P, Saraste A, Reeps C, Metz S, Seidl S, Kessler H, Wester HJ, Eckstein HH, Schwaiger M.

JACC Cardiovasc Imaging. 2014 Feb;7(2):178-87. doi: 10.1016/j.jcmg.2013.12.003. Epub 2014 Jan 8.

15.

Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts.

Terry SY, Abiraj K, Frielink C, van Dijk LK, Bussink J, Oyen WJ, Boerman OC.

J Nucl Med. 2014 Feb;55(2):281-6. doi: 10.2967/jnumed.113.129668. Epub 2014 Jan 9.

16.

First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor Targeting.

Baum RP, Kulkarni HR, Müller D, Satz S, Danthi N, Kim YS, Brechbiel MW.

Cancer Biother Radiopharm. 2015 May;30(4):152-9. doi: 10.1089/cbr.2014.1747.

17.

[⁶⁸Ga]NS₃-RGD and [⁶⁸Ga] Oxo-DO3A-RGD for imaging α(v)β₃ integrin expression: synthesis, evaluation, and comparison.

Knetsch PA, Petrik M, Rangger C, Seidel G, Pietzsch HJ, Virgolini I, Decristoforo C, Haubner R.

Nucl Med Biol. 2013 Jan;40(1):65-72. doi: 10.1016/j.nucmedbio.2012.09.006. Epub 2012 Oct 26.

PMID:
23102540
18.

Imaging of αvβ3 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography.

Grönman M, Tarkia M, Kiviniemi T, Halonen P, Kuivanen A, Savunen T, Tolvanen T, Teuho J, Käkelä M, Metsälä O, Pietilä M, Saukko P, Ylä-Herttuala S, Knuuti J, Roivainen A, Saraste A.

J Transl Med. 2017 Jun 19;15(1):144. doi: 10.1186/s12967-017-1245-1.

19.

(68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.

Li ZB, Chen K, Chen X.

Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1100-8. doi: 10.1007/s00259-007-0692-y. Epub 2008 Jan 19.

PMID:
18204838
20.

Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

Aichler M, Seiler C, Tost M, Siveke J, Mazur PK, Da Silva-Buttkus P, Bartsch DK, Langer P, Chiblak S, Dürr A, Höfler H, Klöppel G, Müller-Decker K, Brielmeier M, Esposito I.

J Pathol. 2012 Apr;226(5):723-34. doi: 10.1002/path.3017. Epub 2012 Jan 17.

PMID:
21984419

Supplemental Content

Support Center